Sale!

HMG 75iu – 75iu/vial + water

Original price was: 41,42 €.Current price is: 36,27 €.

HMG 75 IU DRIADA MEDICAL (Bacteriostatic water) Description Human Menopausal Gonadotropin (hMG) Is a hormonally effective drug for the treatment of fertility disorders in men and women. This is a mixture of gonadotropins – the follicle -stimulating hormone (FSH) and the luteinizing hormone (LH). Mechanism of action of HMG 75iu Driada Medical (bacteriostatic water) As soon as HMG is injected, Will it be over that

Category:

Description

HMG 75 IU DRIADA MEDICAL (Bacteriostatic water) DESCRIPTION

Human Menopausal Gonadotropin (hMG) is a hormonally active drug used to treat fertility disorders in men and women. It is a mixture of gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

Mechanism of action of HMG 75 IU Driada Medical (bacteriostatic water)

Once HMG is injected, it is absorbed through the muscle tissue and released into the body. Since HMG can be used regularly to increase testosterone production in the body, it is very popular in anti-aging clinics and biotechnology companies.

HMG differs from hCG: hCG is a molecule that binds mainly to LH receptors (Leydig cells) and very little to FSH receptors (Sertoli cells), whereas HMG binds more naturally to both LH and FSH receptors.

hCG increases intratesticular testosterone, while HMG also promotes the differentiation and maturation of sperm.

HMG 75 IU Driada Medical (bacteriostatic water) contains FSH, which has a significant impact on sperm production, testicle size, libido, and mood. A lack of FSH signaling is also involved in the development of affective disorders.

HMG 75 IU Driada Medical (bacteriostatic water) is mainly excreted through the kidneys. The pharmacokinetics of HMG in patients with restricted kidney or liver function have not been examined.

Bacteriostatic water. Purpose of use

It was developed to treat female infertility but is also used by men as part of hormone replacement therapy. In fact, HMG is often used in the bodybuilding world to significantly improve post-cycle therapy (PCT). During the cycle, hCG is used as a source of luteinizing hormone (LH) bioactivity to stimulate testosterone secretion via Leydig cells, support their activity, and prevent atrophy, while HMG is used as a source of FSH to stimulate and maintain Sertoli cells.

It is extremely important during an anabolic steroid cycle to maintain testicular activity, avoid complete testicular atrophy, and maintain the steroidogenesis cascade—the dozens of secondary hormones and compounds produced, which play an important role in both mental and somatic well-being. HMG thus ensures comprehensive stimulation of testicular activity during the cycle or during PCT. Studies have shown that HMG, in combination with hCG, restores fertility even after long steroid cycles and during TRT. A current meta-analysis showed that recovery after the cycle is better when hCG is combined with HMG.

How to use the medication

Treatment with HMG should be initiated under the supervision of a doctor experienced in treating fertility problems. There are significant inter-individual differences in the ovarian response to exogenous gonadotropins. This makes it impossible to set a uniform dosage regimen. The dosage should therefore be individually adapted to the ovarian response. HMG can be administered alone or in combination with a GnRH agonist or antagonist. Recommendations for dosage and treatment duration may change depending on the specific treatment protocols:

To maintain fertility and testicular activity, HMG should be used in cycles lasting no longer than 10 weeks. Ideally, it should be used from the first week to avoid testicular atrophy. Prevention of testicular atrophy is most commonly needed within 3–4 weeks after a steroid cycle. However, in cases where cycles last longer than 10 weeks and lead to a complete loss of testicular function, it is necessary to start hCG/HMG treatment as early as possible. In this case, the protocol is: HMG at 75–150 IU 2–3 times/week and/or hCG at 250–500 IU 2–3 times/week.

For individuals suffering from hypogonadotropic hypogonadism, it is recommended to take 5–10 IU per day over several months.

Athletes looking for a way to improve their performance may take up to 10 IU per day. On training days, a dose of 30 IU can be taken 5 minutes before the start of the workout.

For severe azoospermia induced by anabolic steroids, the protocol using human chorionic gonadotropin (hCG) and human menopausal gonadotropin (HMG) consists of twice-weekly injections of 10,000 IU hCG and daily injections of 75 IU HMG over a period of 3 months. It is important not to overuse it, as this can lead to overstimulation of the Leydig cells.

How to prepare a solution

To prepare an injection solution, take a syringe that already contains a diluent and inject it into a vial with lyophilized powder. Tilt the vial so that the needle touches the vial wall. Avoid injecting the diluent directly into the lyophilized powder. The solvent should slowly flow down the wall of the vial (do not fill it all at once and take your time). As soon as the entire diluent has been added to the peptide vial, mix carefully (but do not stir or shake the vial) until the lyophilized powder has dissolved and you obtain a clear liquid. Now the drug is ready for use.

Never mix a peptide with another in the same syringe. There is a risk that fragile peptide molecules will be destroyed.

Application

  • Depending on personal preference, the injection can be administered subcutaneously or intramuscularly.

Positive effects

  • Increased endogenous testosterone levels
  • Increased sperm production
  • Increased libido and improved mood
  • Restoration of fertility
  • Preservation of testicular activity during the cycle
  • The possibility of restoring natural testosterone production and fertility after steroid abuse

Side effects

  • Abdominal pain
  • Shortness of breath
  • Breast swelling
  • Breast tenderness
  • Nausea
  • Weight gain
  • Swelling of the hands and feet
  • Mild rash
  • Testicular pain

Medication profile

  • Half-life: LH (half-life 13.8–1020 min) and FSH (half-life 21.3–1090 min)
  • Frequency of administration: Once every 3 days

Contraindications for HMG 75 IU Driada Medical

  • Hypersensitivity to menotropins or any of the other components of Menopur.
  • Women with: Tumors of the pituitary gland or hypothalamus; ovarian, uterine, or breast cancer; gynecological bleeding of unknown etiology; ovarian cysts or enlarged ovaries not due to polycystic ovarian disease.
  • In the following situations, treatment is unlikely to be effective, which is why HMG should not be administered: Primary ovarian failure; malformations of the genital organs that are incompatible with pregnancy; uterine fibroids that are incompatible with pregnancy.
  • Use during pregnancy: HMG is contraindicated in pregnant women.
  • There are no or only limited data on the use of menotropins in pregnant women. No animal studies have been carried out to evaluate the effect of Menopur during pregnancy.
  • Use during breastfeeding: HMG is contraindicated in breastfeeding women.

Bacteriostatic water injections

  1. Injections can be administered subcutaneously and intramuscularly with an insulin syringe.
  2. Disinfect the rubber cap of the vial and the injection site with alcohol.
  3. Draw the medication into a syringe and inject it slowly.

Storage

  • Protect from light
  • Keep in the refrigerator (2-8°C)
  • Do not freeze
  • After reconstitution, the solution can be stored for a maximum of 28 days at no more than 25 °C
  • After dissolving in the supplied solvent, the solution should be administered immediately
  • Keep away from children
  • Do not use after the expiry date